July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Eric Singhi on Progress in SCLC with ABBV-706 Early-Phase Data
Jul 1, 2025, 08:59

Eric Singhi on Progress in SCLC with ABBV-706 Early-Phase Data

Eric Singhi, Thoracic Medical Oncologist at MD Anderson Cancer Center, shared a post on X by DAVA Oncology, adding:

“Exciting to see how the field is moving forward for our patients with SCLC!”

Quoting DAVA Oncology‘s post:

“Dr. Millie Das presented early-phase data on ABBV-706, a novel SEZ6-targeted ADC delivering a topo I payload.
In relapsed/refractory SCLC, ORR reached 60.9%. Safety manageable; biomarker role still unclear.
Combo trials with PD-1/platinum ongoing. “

SCLC

More posts featuring Eric Singhi on OncoDaily.